ATG4B and hepatocellular carcinoma: As shown in Figures 5A–C, miR-543 remarkably alleviated the CRNDE-triggered upregulation of ATG4B at both mRNA and protein levels, and attenuated CRNDE-enhanced ATG4B mRNA stability in HCC cells.